FF
RYTM icon

FourThought Financial’s Rhythm Pharmaceuticals RYTM Stock Holding History

FourThought Financial’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,776
Closed -$7K – 1560
2022
Q2 		$7K Hold
1,776
– – ﹤0.01% 1107
2022
Q1 		$20K Sell
1,776
-383
-18% -$3.36K ﹤0.01% 905
2021
Q4 		$22K Buy
2,159
+1,589
+279% +$17.9K ﹤0.01% 908
2021
Q3 		$7K Buy
+570
New +$8.7K ﹤0.01% 1171

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FourThought Financial's RYTM Position: Q3 2022 in Review

FourThought Financial sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2022, closing a stake of 1,776 shares — an estimated $7K sold.

FourThought Financial first reported a position in RYTM in Q3 2021 and held it in 4 quarters. The position peaked at $22K in Q4 2021. 101 funds tracked by Wall St. Rank hold RYTM as of Q3 2022.

  • FourThought Financial reported no remaining Rhythm Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • FourThought Financial sold 1,776 Rhythm Pharmaceuticals shares in Q3 2022, an estimated $7K.
  • FourThought Financial first reported a position in Rhythm Pharmaceuticals in Q3 2021 and held it in 4 quarters.
  • FourThought Financial's Rhythm Pharmaceuticals position peaked at $22K in Q4 2021.
  • 101 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.